What does a fecal calprotectin level of 53 µg/g indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What Does a Fecal Calprotectin of 53 µg/g Mean?

A fecal calprotectin level of 53 µg/g is considered normal and effectively rules out significant intestinal inflammation in most clinical contexts, particularly if you are asymptomatic or have only mild gastrointestinal symptoms.

Clinical Interpretation

Your calprotectin level of 53 µg/g falls just above the traditional cutoff of 50 µg/g but well below the clinically significant threshold of 150 µg/g that guidelines use to indicate active inflammation 1.

Key Context from Guidelines:

  • In symptomatic remission (no bleeding, normal stool frequency): Calprotectin <150 ± 50 µg/g reliably rules out active inflammation, making endoscopy unnecessary 1
  • With mild symptoms: Even calprotectin <150 µg/g cannot completely rule out inflammation, but levels this low make significant disease unlikely 1
  • Diagnostic performance: At the 50 µg/g cutoff, the test has 78% sensitivity but only 57% specificity for detecting moderate-to-severe inflammation 1

What This Means for You

If you have no symptoms or are in remission:

  • This level is reassuring and suggests no significant intestinal inflammation
  • No immediate action needed; repeat testing in 3-6 months if symptoms develop 1

If you have mild GI symptoms (occasional loose stools, mild abdominal discomfort):

  • The level is still reassuring, but doesn't completely exclude inflammation
  • Your symptoms are more likely functional (like irritable bowel syndrome) than inflammatory
  • If symptoms persist or worsen, endoscopy may still be warranted despite the normal calprotectin 1

If you have moderate-to-severe symptoms (frequent bloody diarrhea, significant pain, weight loss):

  • This normal calprotectin level does NOT rule out serious disease
  • You should proceed directly to endoscopic evaluation regardless of this result 1

Important Caveats

The 53 µg/g level sits in a "gray zone" just above 50 µg/g. While guidelines use 50 µg/g as a cutoff, they acknowledge variability (50 ± 50 µg/g range) 1. Your level is essentially at the upper limit of normal.

Other factors that can mildly elevate calprotectin without IBD:

  • Age (higher in young children and potentially older adults) 2, 3
  • Recent NSAID use
  • Infections (though usually >150 µg/g)
  • Day-to-day variation 4

Bottom Line Algorithm

  1. No symptoms + FC 53 µg/g → Reassuring, no action needed
  2. Mild symptoms + FC 53 µg/g → Likely functional; consider repeat testing in 3-6 months if symptoms persist 1
  3. Moderate-severe symptoms + FC 53 µg/g → Proceed to colonoscopy; calprotectin doesn't rule out disease in symptomatic patients 1

The negative predictive value is excellent at this level - meaning if you're asymptomatic or mildly symptomatic, you can be confident you don't have active inflammatory bowel disease 5, 4.

References

Research

Evaluating the role of faecal calprotectin in older adults: a retrospective observational study.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2026

Research

Fecal Calprotectin.

Advances in clinical chemistry, 2018

Research

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases.

Clinical and translational gastroenterology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.